Drug class · Neurology & psychiatry
Atypical antipsychotics Drug Codes & NDCs
Second-generation antipsychotics, including oral products and long-acting injectables.
FDA-listed products
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Invegapaliperidone | Paliperidone 9 mg/1 | Tablet, Extended releaseOral | Janssen Pharmaceuticals, Inc. | 50458-552 |
| Invegapaliperidone | Paliperidone 1.5 mg/1 | Tablet, Extended releaseOral | Janssen Pharmaceuticals, Inc. | 50458-554 |
| Invega Hafyerapaliperidone palmitate | Paliperidone palmitate 1092 mg/3.5mL | Injection, Suspension, Extended releaseIntramuscular | Janssen Pharmaceuticals, Inc | 50458-611 |
| Invega Hafyerapaliperidone palmitate | Paliperidone palmitate 1560 mg/5mL | Injection, Suspension, Extended releaseIntramuscular | Janssen Pharmaceuticals, Inc | 50458-612 |
| Invega Sustennapaliperidone palmitate | Paliperidone palmitate 39 mg/.25mL | InjectionIntramuscular | Janssen Pharmaceuticals, Inc. | 50458-560 |
| Invega Sustennapaliperidone palmitate | Paliperidone palmitate 78 mg/.5mL | InjectionIntramuscular | Janssen Pharmaceuticals, Inc. | 50458-561 |
| Invega Sustennapaliperidone palmitate | Paliperidone palmitate 117 mg/.75mL | InjectionIntramuscular | Janssen Pharmaceuticals, Inc. | 50458-562 |
| Invega Sustennapaliperidone palmitate | Paliperidone palmitate 156 mg/mL | InjectionIntramuscular | Janssen Pharmaceuticals, Inc. | 50458-563 |
| Invega Sustennapaliperidone palmitate | Paliperidone palmitate 234 mg/1.5mL | InjectionIntramuscular | Janssen Pharmaceuticals, Inc. | 50458-564 |
| Invega Trinzapaliperidone palmitate | Paliperidone palmitate 273 mg/.88mL | Injection, Suspension, Extended releaseIntramuscular | Janssen Pharmaceuticals, Inc | 50458-606 |
| Invega Trinzapaliperidone palmitate | Paliperidone palmitate 410 mg/1.32mL | Injection, Suspension, Extended releaseIntramuscular | Janssen Pharmaceuticals, Inc | 50458-607 |
| Invega Trinzapaliperidone palmitate | Paliperidone palmitate 546 mg/1.75mL | Injection, Suspension, Extended releaseIntramuscular | Janssen Pharmaceuticals, Inc | 50458-608 |
| Invega Trinzapaliperidone palmitate | Paliperidone palmitate 819 mg/2.63mL | Injection, Suspension, Extended releaseIntramuscular | Janssen Pharmaceuticals, Inc | 50458-609 |
| Latudalurasidone hydrochloride | Lurasidone hydrochloride 20 mg/1 | Tablet, Film coatedOral | Sumitomo Pharma America, Inc. | 63402-302 |
| Latudalurasidone hydrochloride | Lurasidone hydrochloride 40 mg/1 | Tablet, Film coatedOral | Sumitomo Pharma America, Inc. | 63402-304 |
| Latudalurasidone hydrochloride | Lurasidone hydrochloride 60 mg/1 | Tablet, Film coatedOral | Sumitomo Pharma America, Inc. | 63402-306 |
| Latudalurasidone hydrochloride | Lurasidone hydrochloride 80 mg/1 | Tablet, Film coatedOral | Sumitomo Pharma America, Inc. | 63402-308 |
| Latudalurasidone hydrochloride | Lurasidone hydrochloride 120 mg/1 | Tablet, Film coatedOral | Sumitomo Pharma America, Inc. | 63402-312 |
| Lurasidone HCL | Lurasidone hydrochloride 40 mg/1 | TabletOral | Direct_rx | 72189-598 |
| lurasidone hydrochloride | Lurasidone hydrochloride 20 mg/1 | Tablet, Film coatedOral | Major Pharmaceuticals | 0904-7355 |
| lurasidone hydrochloride | Lurasidone hydrochloride 40 mg/1 | Tablet, Film coatedOral | Major Pharmaceuticals | 0904-7356 |
| lurasidone hydrochloride | Lurasidone hydrochloride 60 mg/1 | Tablet, Film coatedOral | Major Pharmaceuticals | 0904-7357 |
| lurasidone hydrochloride | Lurasidone hydrochloride 80 mg/1 | Tablet, Film coatedOral | Major Pharmaceuticals | 0904-7358 |
| lurasidone hydrochloride | Lurasidone hydrochloride 120 mg/1 | Tablet, Film coatedOral | Major Pharmaceuticals | 0904-7359 |
| lurasidone hydrochloride | Lurasidone hydrochloride 20 mg/1 | Tablet, Film coatedOral | MAJOR PHARMACEUTICALS | 0904-7421 |